Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falko Fend

Showing results (211-220 of 399) with videos related to

Pageof 40
Sort By:
Oncogene|August 17, 2019
Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9Kathy-Ann Secker, Hildegard Keppeler, Silke Duerr-Stoerzer, et al.
International Journal of Molecular Sciences|July 28, 2022
Multiparametric Classification of Non-Muscle Invasive Papillary Urothelial Neoplasms: Combining Morphological, Phenotypical, and Molecular Features for Improved Risk StratificationIvonne A Montes-Mojarro, Saki Hassas, Sina Staehle, et al.
British Journal of Haematology|March 12, 2015
BRAF(V600E) mutations are found in Richter syndrome and may allow targeted therapy in a subset of patientsRob S Sellar, Falko Fend, Ayse U Akarca, et al.
Deutsche Medizinische Wochenschrift (1946)|September 20, 2016
[An unexpected cause of dyspnea and degradation of performance]Peter Seizer, Michaela Rockenstiehl, Suzanne Fateh-Moghadam, et al.
Journal of Cancer Research and Clinical Oncology|April 23, 2019
Assessment of concomitant non-oncologic medication in patients with surgically treated renal cell carcinoma: impact on prognosis, cell-cycle progression and proliferationEva Neumann, Peter Klaiber, Kathleen Freitag, et al.
Histopathology|July 20, 2010
ERG rearrangement in small cell prostatic and lung cancerVeit J Scheble, Martin Braun, Theresia Wilbertz, et al.
Haematologica|July 18, 2009
Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCRLeticia Quintanilla-Martinez, Julia Slotta-Huspenina, Ina Koch, et al.
Virchows Archiv : an International Journal of Pathology|August 28, 2019
Comprehensive in situ analysis of ALDH1 and SOX2 reveals increased expression of stem cell markers in high-grade serous carcinomas compared to low-grade serous carcinomas and atypical proliferative serous tumorsAnna Katharina Fischer, Deborah L Pham, Hans Bösmüller, et al.
Translational Vision Science & Technology|January 27, 2026
DECODE VRL Report No. 1: Lymphocyte Survival After Diagnostic Vitrectomy - Does Size Matter?Martin Kowalski, Vinodh Kakkassery, David Adrian Merle, et al.
Virchows Archiv : an International Journal of Pathology|June 3, 2017
B-cell lymphomas with discordance between pathological features and clinical behaviorLaurence de Leval, Christiane Copie-Bergman, Andreas Rosenwald, et al.
Pageof 40

Showing results (211-220 of 399) with videos related to

Sort By:
Pageof 40
Oncogene|August 17, 2019
Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9Kathy-Ann Secker, Hildegard Keppeler, Silke Duerr-Stoerzer, et al.
International Journal of Molecular Sciences|July 28, 2022
Multiparametric Classification of Non-Muscle Invasive Papillary Urothelial Neoplasms: Combining Morphological, Phenotypical, and Molecular Features for Improved Risk StratificationIvonne A Montes-Mojarro, Saki Hassas, Sina Staehle, et al.
British Journal of Haematology|March 12, 2015
BRAF(V600E) mutations are found in Richter syndrome and may allow targeted therapy in a subset of patientsRob S Sellar, Falko Fend, Ayse U Akarca, et al.
Deutsche Medizinische Wochenschrift (1946)|September 20, 2016
[An unexpected cause of dyspnea and degradation of performance]Peter Seizer, Michaela Rockenstiehl, Suzanne Fateh-Moghadam, et al.
Journal of Cancer Research and Clinical Oncology|April 23, 2019
Assessment of concomitant non-oncologic medication in patients with surgically treated renal cell carcinoma: impact on prognosis, cell-cycle progression and proliferationEva Neumann, Peter Klaiber, Kathleen Freitag, et al.
Histopathology|July 20, 2010
ERG rearrangement in small cell prostatic and lung cancerVeit J Scheble, Martin Braun, Theresia Wilbertz, et al.
Haematologica|July 18, 2009
Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCRLeticia Quintanilla-Martinez, Julia Slotta-Huspenina, Ina Koch, et al.
Virchows Archiv : an International Journal of Pathology|August 28, 2019
Comprehensive in situ analysis of ALDH1 and SOX2 reveals increased expression of stem cell markers in high-grade serous carcinomas compared to low-grade serous carcinomas and atypical proliferative serous tumorsAnna Katharina Fischer, Deborah L Pham, Hans Bösmüller, et al.
Translational Vision Science & Technology|January 27, 2026
DECODE VRL Report No. 1: Lymphocyte Survival After Diagnostic Vitrectomy - Does Size Matter?Martin Kowalski, Vinodh Kakkassery, David Adrian Merle, et al.
Virchows Archiv : an International Journal of Pathology|June 3, 2017
B-cell lymphomas with discordance between pathological features and clinical behaviorLaurence de Leval, Christiane Copie-Bergman, Andreas Rosenwald, et al.
Pageof 40